Merit Medical Systems, Inc. (MMSI) — Financial statements
Income statement, balance sheet, and cash flow for Merit Medical Systems, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,515↑11.7% | 1,357↑7.9% | 1,257↑9.2% | 1,151↑7.1% | 1,075 | |
| Cost of Revenue | 778↑9.1% | 713↑5.9% | 673↑6.6% | 632↑7.2% | 589 | |
| Gross Profit | 737↑14.6% | 643↑10.2% | 584↑12.5% | 519↑7.0% | 485 | |
| Operating Expenses | ||||||
| R&D Expenses | 97↑16.2% | 84↑1.3% | 83↑9.6% | 76↑6.0% | 71 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 455↑20.8% | 377↑0.8% | 374↑9.1% | 343↑2.0% | 336 | |
| Other Expenses | 0.00↓100.0% | 27↑668.8% | 4↓73.9% | 14↓22.8% | 17 | |
| Operating Expenses | 553↑13.3% | 488↑6.3% | 459↑6.3% | 432↑1.7% | 424 | |
| Total Costs & Expenses | 1,330↑10.8% | 1,201↑5.9% | 1,133↑6.6% | 1,063↑4.9% | 1,014 | |
| Operating Results | ||||||
| Operating Income | 184↑18.4% | 156↑25.6% | 124↑41.5% | 88↑43.7% | 61 | |
| Depreciation & Amortization | 135↑17.4% | 115↑13.3% | 101↑9.9% | 92↓3.7% | 96 | |
| EBITDA | 319↑16.4% | 274↑19.7% | 229↑26.3% | 181↑16.9% | 155 | |
| EBIT | 184↑15.8% | 159↑24.8% | 128↑43.4% | 89↑50.3% | 59 | |
| Interest & Other Income | ||||||
| Net Interest Income | -11↓128.3% | -5↑61.8% | -13↓121.3% | -6↓31.3% | -4 | |
| Interest Income | 15↓42.5% | 26↑968.0% | 2↑459.5% | 0.44↓42.9% | 0.77 | |
| Interest Expense | 26↓15.2% | 31↑101.3% | 16↑144.7% | 6↑20.5% | 5 | |
| Non-Operating Income | 0.00↑100.0% | -4↑3.1% | -4↓160.2% | -1↓180.8% | 2 | |
| Other Income / Expenses | -13↓135.8% | -6↑51.9% | -12↓140.3% | -5↑29.5% | -7 | |
| Income Before Tax | 171↑14.0% | 150↑33.8% | 112↑35.7% | 83↑53.3% | 54 | |
| Income Tax Expense | 42↑43.2% | 30↑67.6% | 18↑117.9% | 8↑48.5% | 5 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 128↑6.8% | 120↑27.5% | 94↑26.7% | 75↑53.8% | 48 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 128↑6.8% | 120↑27.5% | 94↑26.7% | 75↑53.8% | 48 | |
| Bottom-Line Net Income | 128↑6.8% | 120↑27.5% | 94↑26.7% | 75↑53.8% | 48 | |
| EPS (Basic) | 2.17↑4.8% | 2.07↑26.2% | 1.64↑25.2% | 1.31↑52.3% | 0.86 | |
| EPS (Diluted) | 2.13↑4.9% | 2.03↑25.3% | 1.62↑25.6% | 1.29↑53.6% | 0.84 | |
| Weighted Average Shares | 59↑1.6% | 58↑1.1% | 58↑1.4% | 57↑1.2% | 56 | |
| Weighted Average Diluted Shares | 60↑1.8% | 59↑1.7% | 58↑1.2% | 58↑0.5% | 57 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.